Search - tctmd.com

Displaying 341 - 360 of 536

Sort: Relevancy | Date

News Daily News

Intracoronary ACE Inhibitor Reduces Microvascular Damage in Elective PCI

Yael L. Maxwell

January 06, 2013

News Daily News

Stent Thrombosis During PCI Rare but Serious Phenomenon

Yael L. Maxwell

December 26, 2012

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

Yael L. Maxwell

December 19, 2012

News Industry News

St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

December 17, 2012

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

News Conference News AHA 2012

Cell Therapy Trials Show Mixed Results at AHA 2012

November 05, 2012

Presentation AHA 2012

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

Presenter: Weon Kim

November 04, 2012

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

News Conference News AHA 2012

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

November 04, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

News Industry News

Trial Finds Benefits to Using Radial Versus Femoral Access for Primary Angioplasty in Heart Attack Patients

October 26, 2012

News Industry News

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

October 26, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Industry News

The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions

October 23, 2012

Advertisement

Intracoronary ACE Inhibitor Reduces Microvascular Damage in Elective PCI

Stent Thrombosis During PCI Rare but Serious Phenomenon

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Cell Therapy Trials Show Mixed Results at AHA 2012

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Trial Finds Benefits to Using Radial Versus Femoral Access for Primary Angioplasty in Heart Attack Patients

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content